miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin.
Wnt signaling pathways are essential for bone formation. Previous studies showed that Wnt signaling pathways were regulated by miR-375. Thus, we aim to explore whether miR-375 could affect osteogenesis. In the present study, we investigated the roles of miR-375 and its downstream targets. Firstly, w...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171281&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850079025170481152 |
|---|---|
| author | Tianhao Sun Chen-Tian Li Lifeng Xiong Ziyu Ning Frankie Leung Songlin Peng William W Lu William W Lu |
| author_facet | Tianhao Sun Chen-Tian Li Lifeng Xiong Ziyu Ning Frankie Leung Songlin Peng William W Lu William W Lu |
| author_sort | Tianhao Sun |
| collection | DOAJ |
| description | Wnt signaling pathways are essential for bone formation. Previous studies showed that Wnt signaling pathways were regulated by miR-375. Thus, we aim to explore whether miR-375 could affect osteogenesis. In the present study, we investigated the roles of miR-375 and its downstream targets. Firstly, we revealed that miR-375-3p negatively modulated osteogenesis by suppressing positive regulators of osteogenesis and promoting negative regulators of osteogenesis. In addition, the results of TUNEL cell apoptosis assay showed that miR-375-3p induced MC3T3-E1 cell apoptosis. Secondly, miR-375-3p targeted low-density lipoprotein receptor-related protein 5 (LRP5), a co-receptor of the Wnt signaling pathways, and β-catenin as determined by luciferase activity assay, and it decreased the expression levels of LRP5 and β-catenin. Thirdly, the decline of protein levels of β-catenin was determined by immunocytochemistry and immunofluorescence. Finally, silence of LRP5 in osteoblast precursor cells resulted in diminished cell viability and cell proliferation as detected by WST-1-based colorimetric assay. Additionally, all the parameters including the relative bone volume from μCT measurement suggested that LRP5 knockout in mice resulted in a looser and worse-connected trabeculae. The mRNA levels of important negative modulators relating to osteogenesis increased after the functions of LRP5 were blocked in mice. Last but not least, the expression levels of LRP5 increased during the osteogenesis of MC3T3-E1, while the levels of β-catenin decreased in bone tissues from osteoporotic patients with vertebral compression fractures. In conclusion, we revealed miR-375-3p negatively regulated osteogenesis by targeting LRP5 and β-catenin. In addition, loss of functions of LRP5 damaged bone formation in vivo. Clinically, miR-375-3p and its targets might be used as diagnostic biomarkers for osteoporosis and might be also as novel therapeutic agents in osteoporosis treatment. The relevant products of miR-375-3p might be developed into molecular drugs in the future. These molecules could be used in translational medicine. |
| format | Article |
| id | doaj-art-eb44f810ad0948088a05e8faa6b20451 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-eb44f810ad0948088a05e8faa6b204512025-08-20T02:45:23ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017128110.1371/journal.pone.0171281miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin.Tianhao SunChen-Tian LiLifeng XiongZiyu NingFrankie LeungSonglin PengWilliam W LuWilliam W LuWnt signaling pathways are essential for bone formation. Previous studies showed that Wnt signaling pathways were regulated by miR-375. Thus, we aim to explore whether miR-375 could affect osteogenesis. In the present study, we investigated the roles of miR-375 and its downstream targets. Firstly, we revealed that miR-375-3p negatively modulated osteogenesis by suppressing positive regulators of osteogenesis and promoting negative regulators of osteogenesis. In addition, the results of TUNEL cell apoptosis assay showed that miR-375-3p induced MC3T3-E1 cell apoptosis. Secondly, miR-375-3p targeted low-density lipoprotein receptor-related protein 5 (LRP5), a co-receptor of the Wnt signaling pathways, and β-catenin as determined by luciferase activity assay, and it decreased the expression levels of LRP5 and β-catenin. Thirdly, the decline of protein levels of β-catenin was determined by immunocytochemistry and immunofluorescence. Finally, silence of LRP5 in osteoblast precursor cells resulted in diminished cell viability and cell proliferation as detected by WST-1-based colorimetric assay. Additionally, all the parameters including the relative bone volume from μCT measurement suggested that LRP5 knockout in mice resulted in a looser and worse-connected trabeculae. The mRNA levels of important negative modulators relating to osteogenesis increased after the functions of LRP5 were blocked in mice. Last but not least, the expression levels of LRP5 increased during the osteogenesis of MC3T3-E1, while the levels of β-catenin decreased in bone tissues from osteoporotic patients with vertebral compression fractures. In conclusion, we revealed miR-375-3p negatively regulated osteogenesis by targeting LRP5 and β-catenin. In addition, loss of functions of LRP5 damaged bone formation in vivo. Clinically, miR-375-3p and its targets might be used as diagnostic biomarkers for osteoporosis and might be also as novel therapeutic agents in osteoporosis treatment. The relevant products of miR-375-3p might be developed into molecular drugs in the future. These molecules could be used in translational medicine.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171281&type=printable |
| spellingShingle | Tianhao Sun Chen-Tian Li Lifeng Xiong Ziyu Ning Frankie Leung Songlin Peng William W Lu William W Lu miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin. PLoS ONE |
| title | miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin. |
| title_full | miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin. |
| title_fullStr | miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin. |
| title_full_unstemmed | miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin. |
| title_short | miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin. |
| title_sort | mir 375 3p negatively regulates osteogenesis by targeting and decreasing the expression levels of lrp5 and β catenin |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171281&type=printable |
| work_keys_str_mv | AT tianhaosun mir3753pnegativelyregulatesosteogenesisbytargetinganddecreasingtheexpressionlevelsoflrp5andbcatenin AT chentianli mir3753pnegativelyregulatesosteogenesisbytargetinganddecreasingtheexpressionlevelsoflrp5andbcatenin AT lifengxiong mir3753pnegativelyregulatesosteogenesisbytargetinganddecreasingtheexpressionlevelsoflrp5andbcatenin AT ziyuning mir3753pnegativelyregulatesosteogenesisbytargetinganddecreasingtheexpressionlevelsoflrp5andbcatenin AT frankieleung mir3753pnegativelyregulatesosteogenesisbytargetinganddecreasingtheexpressionlevelsoflrp5andbcatenin AT songlinpeng mir3753pnegativelyregulatesosteogenesisbytargetinganddecreasingtheexpressionlevelsoflrp5andbcatenin AT williamwlu mir3753pnegativelyregulatesosteogenesisbytargetinganddecreasingtheexpressionlevelsoflrp5andbcatenin AT williamwlu mir3753pnegativelyregulatesosteogenesisbytargetinganddecreasingtheexpressionlevelsoflrp5andbcatenin |